Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia

Am J Ther. 2013 Nov-Dec;20(6):e703-5. doi: 10.1097/MJT.0b013e3181d56671.

Abstract

Valproate-associated hyperammonemic coma in adults is a rare complication of valproate therapy and has been previously reported to occur in few days to years after initiation of therapy. We present a case of hyperammonemic coma induced within hours of initiating valproate therapy in a patient with plasma carnitine deficiency.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticonvulsants / adverse effects*
  • Anticonvulsants / therapeutic use
  • Carnitine / blood
  • Carnitine / deficiency*
  • Coma / chemically induced*
  • Female
  • Humans
  • Time Factors
  • Valproic Acid / adverse effects*
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Valproic Acid
  • Carnitine